Clenbuterol anticorps

N° du produit ABIN965905

Cet anticorps Monoclonal détecte spécifiquement dans ELISA. Il présente une réactivité envers et a été mentionné dans 2+ publications.

Aperçu rapide pour Clenbuterol anticorps (ABIN965905)

Antigène: Clenbuterol

Hôte: Veuillez nous consulter SVP

Clonalité: Monoclonal

Conjugué: Inconjugué

Application: ELISA

Détail du produit

Specificité: Clenbuterol- KLH.

Purification: Antibodies are purified by protein G affinity chromatography.

Isotype: IgG1

Information d'application

Indications d'application: ELISA: Propose dilution 1: 10,000.
Determining optimal working dilutions by titration test.

Restrictions: For Research Use only

Stockage

Stock: -20 °C

Référence

Aharoni, Dantes, Oren, Amsterdam: "cAMP-mediated signals as determinants for apoptosis in primary granulosa cells." dans: Experimental cell research, Vol. 218, Issue 1, pp. 271-82, (1995) (PubMed).

Hoshi, Furutani-Seiki, Seto, Tada, Asano: "Prevention of TCR-mediated apoptosis by the elevation of cAMP." dans: International immunology, Vol. 6, Issue 7, pp. 1081-9, (1994) (PubMed).

Détail du antigène

Antigène: Clenbuterol

Classe de substances: Chemical

Sujet: Clenbuterol belongs to the group of agonists. In livestock production clenbuterol improves the meat/fat ratio in fattened animals or accelerate the growth. Up to now agonists have not been authorized as adjuvants for fattening. In addition to its lipolytic and anabolic effect, clenbuterol has a relaxing effect on non-striated musculature on which is based its therapeutic use as an antiasthmatic and a tocolytic agent. When employed as a fattening adjuvant, as compared with the therapeutic use, clenbuterol is administered in a 5 to 10 times higher dose. Therefore, it is possible that clenbuterol residues may lead to a risk for consumers after illegal administration. Using the clenbuterol monocalantibody, it is possible to detect clenbuterol and other agonists in urine, muscle and liver both rapidly and with accuracy.